Vaccines

SwineCast 0932, Elanco's New Vaccine Innovation Center Looks To The Future

SwineCast 0932 Show Notes:
  • John Blue talks with Aaron Schacht, Vice President of Elanco’s Global Research and Development about the challenges of innovation, location and Elanco's focus on world food needs by 2050.

SwineCast 0931, ATM - Maximize Value Through Good Gilt Introduction Protocols

SwineCast 0931 Show Notes:

SwineCast 0927, Aptimmune Offering New Vaccination Technology

SwineCast 0927 Show Notes:
  • Aptimmune Biologics is bringing new intra-nasal vaccination technology to the swine industry.  CEO Aaron Gilbertie discusses the company's focus and products at World Pork Expo.

Using Complexity Theory To Understand Swine Vaccine Responses

 The Importance of Tissue-Level ActivityThe Chaos of Vaccine Responses: The Importance of Tissue-Level Activity Dr. David Hurley, Department of Large Animal Medicine, University of Georgia, dives into the science and physiology of tissue level activity and using Chaos Theory (or Complexity Theory if you prefer) to understand vaccine responses. This presentation shares detailed illustrations that explain tissue level events (their duration and strength plus their diversity).

One key takeaway is vaccines are able to protect target tissues other than the vaccine site because once ordered and produced in effective quantity and for the right challenge, the products will enter all body tissues expressing damage and danger. [video].

Dr. Jeff Galvin - Utilization of Modern Scientific Technologies to Produce Compatible Antigens for Swine Vaccines


Utilization of Modern Scientific Technologies to Produce Compatible Antigens for Swine Vaccines - Dr. Jeff Galvin, Zoetis, from the 2015 North American PRRS Symposium, December 4 - 5, 2015, Chicago, IL, USA.

SwineCast 0893, Vaccine for Ileitis Providing Good ROI

SwineCast 0893 Show Notes:
  • Dr. Mike Eisenmenger from Swine Vet Services discusses their use of Enterisol vaccine on Lawsonia-based Ileitis in their client operations.
  • Additional background info

SwineCast 0872, ATM - Developing PED Immunity

SwineCast 0872 Show Notes:
  • The Morrison Group discusses the transfer and development of Porcine Epidemic Diarrhea Virus with Dr. Linda Saif, professor at the Center for Microbial Interface Biology at The Ohio State University.  Dr. Saif presented at this year's AASV conference and will be delivering a keynote presentation at the 2015 Leman Conference coming in September.

SwineCast 0863, 'At The Meeting' Discusses PCV2 Vertical Transmission - Part 3 of 3

SwineCast 0863 Show Notes:
  • The Morrison Group reviews research and experiences in sow herd vaccination impact on PCV2 (Porcine Circovirus Type 2) vertical transmission in this episode of At The Meeting.  (Episode 3 of 3)
GUESTS:
Dr. Jessica Seate, Murphy-Brown LLC
Dr. Dave Baumert, Cargill Pork
Dr. Brian Payne, Boehringer Ingelheim Vetmedica

Research papers:

SwineCast 0862, 'At The Meeting' Discusses PCV2 Vaccines - Part 2 of 3

SwineCast 0862 Show Notes:
  • The Morrison Group discusses PCV2 (Porcine Circovirus Type 2) vaccines and industry impact in this episode of At The Meeting.  (Episode 2 of 3)
GUESTS:
Dr. Jessica Seate, Murphy-Brown LLC
Dr. Dave Baumert, Cargill Pork
Dr. Brian Payne, Boehringer Ingelheim Vetmedica

Research papers:

How is Salmonella To Be Handled?

Salmonella Choleraesuis and Salmonella TyphimuriumWhat Are Approaches to Salmonella Choleraesuis and Salmonella Typhimurium? Dr. Greg Cline, Dr. John Kolb, and Mike Steilen all share information on Boehringer Ingelheim's Enterisol® Salmonella vaccine. Each provides a view on research, farm use, and marketing perspective [Dr. Greg Cline][Dr. John Kolb][Mike Steilen].
Syndicate content